.

 


Find more photos like this on MedicsIndex.net - Family Safe Pages.com - Medical Social Network

 

 

 

 

 
 
 

 

 

 

 

HOME| Contact

Copyrights 1995-2007 Created and maintained by MBC

 

MEDICSINDEX

 

 

 
 

 

 

 

 
 

 

Marwan Al-Akasheh, MB, BS, FACP

Date of Birth: 8-16-57

                        Place of Birth: Amman

                        Citizenship:  Jordanian           

                        Home address: Kharija Alashjai St.

                                                Building No. 1

                                                Jebel Al- Webdeh

                                                Amman-Jordan

                        Clinic address: Maggi Medical Ctr.

                                                Jebel Amman

                                                Al Khalidi St.

Building No. 19,

Suite 101

                        Mailing address: P. O. Box 9668

   Amman-11191

   Jordan

Tel # +9626-4654999

Fax# +9626-465123

                        E-mail: makasheh@pol.net

 

الدكتور مروان العكشة
 - مستشار الدم والأورام وزراعة النخاع

 - عميد طبيب متقاعد مدينة الحسين الطبية
 - رئيس قسم الدم والاورام وزراعة النخاع
 - خريج كلية الطب في ميلواكي وسكنسن/ أمريكا
 - بورد بالدم والاورام/ زمالة أمريكية
 - عضو بجمعية الدم الأمريكية
 - عضو بجمعية الأورام الأمريكية والأوروبية
 - عضو بجمعية زراعة النخاع الأوروبية
 - زميل كلية الأطباء الأمريكية
 - نائب رئيس جمعية الدم الأردنية

 

           

 

 

 
 

 

Curriculum Vitae

                       

Academic Rank and Position
 

Retired Brigadier General from the Jordanian Royal Medical Services.

X-Chief of Hematology/Oncology & Bone Marrow Transplantation

Department of Internal Medicine,

King Hussein Medical Center

Private Practice 2009

 

Education
 

                        College: La College De la Sale / Amman-Jordan 1963-6/1975.

                        Pre-Medicine / University of Jordan 7/1975-6/1977

                        Medical School / University of Jordan MB, BS. 7/1977-6/1982

                        Internship; Al-Bashir government hospital 7/1982-6/1983

                        Military training 7/1983-11/1983

                        Army Medical Officer 12/1983-12/1984

                        Residency in Internal Medicine / Royal Medical Services

                        Residency 1/1/1985-31/12/1988.

                        Sabbatical in the United Kingdom 1/1/1989-12/31/1989;

                        Whittington Hospital/London advanced internal medicine course

                        National Hospital for Nervous diseases/ London

                        1/1/1994-12/31/1995

Fellowship in Hematology/Oncology: Jordanian Royal Medical Services 12/31/1995- 7/1/1997

Fellowship in Hematology/Oncology: Medical College of Wisconsin/USA 7/1/97- 30/6/2000.

                        Fellowship from the American College of Physicians June 2000.

 

Board Certification

 

                        Boarded in Internal Medicine

                        National Boards United States Medical Licensure Exam; I, II, III

                        Boarded in Hematology and Medical Oncology

 

Medical Licensure & Certificates

 

                        Jordan Medical Association 1983

                        ECFMG certificate 1984

                        Diploma advanced medicine, University of London 1989

Postgraduate fellowship in neurology; National hospital for

Nervous diseases 1989

                        Wisconsin State Medical License/USA # 40824

                        American Drug Enforcement Administration (DEA) License # BA6315483

                        Fellowship in Hematology/Oncology Medical College of Wisconsin 2000.

                        Fellowship of the American College of Physicians (FACP) 2000.

 

 

Honors and Awards

 

Medal of Bravery, the Jordanian army 1994

Oncology Fellowship Award from RPR for 1999

Physician’s Recognition Award Certificate from AMA 2000

Medal of Long and Loyal Service, the Jordanian army 2001

Winner of the International Fellowship Award offered by the          American College of Physicians 2005

 

Military Services

 

Retired Brigadier General from the Jordanian Royal Medical Services.

 

Previous Professional Positions and Appointments

 

Princess Haya Hospital/Aqaba–Jordan (Head of internal Medicine) 

1/1/1990 – 12/31/1991

Prince Zeid Hospital/Tafila-Jordan (Head of internal Medicine)

                        1/1/1994-12/31/1995.

Queen Alia Hospital 1/11992- 12/31/1992 (Member of the Mortality Morbidity Committee).

Princess Haya Hospital/Aqaba–Jordan (Head of internal Medicine) 

1/1/1990 – 12/31/1991

                        Queen Alia Hospital/Amman-Jordan (Internal Medicine Specialist)

                        1/1/1992-12/31/1992

                        Prince Hashem Hospital/Zarka-Jordan (Internal Medicine Specialist)

                        1/1/1993-12/31/1993

Prince Zeid Hospital / Tafila-Jordan (Head of internal Medicine)

King Hussein Medical Center-Amman

Chief of Hematology/Oncology   & BMT Unit.

Attending Oncologist at King Abdalla Hospital-Irbid

Private practice September/01/08

 

Education-Teaching

 

Clinical Instructor at the University of Jordan and King Hussein Medical Center 1995-1997.

                        Member of morbidity mortality committee at Queen Alia Hospital 1993.

                        Seminar moderator at King Hussein medical Center 1995-1997.

Teaching Medical students at the Medical College of Wisconsin. 1997-2000.

Teaching Residents at King Hussein Medical Center.

 

 

Principle Investigator

 

High-Dose cyclophosphamide without stem cell rescue for the treatment of severe autoimmune diseases. (Protocol at the Medical College of Wisconsin).

Waldenstörm macroglobulinemia protocol for patients undergoing autologous bone marrow transplantation. (Protocol at the Medical College of Wisconsin).

High-Dose Chemotherapy for patients with Primary Systemic Amyloidosis. (IBMTR study).

 

Professional and Society Memberships

 

Jordan Medical Association 1982

                        Jordanian Internal Medicine Association 1988

                        American College of Physicians 1995

                        American Society of Clinical Oncology 1997

                        American Medical Association 1997

                        Wisconsin State Medical Society 1997

                        American Society of Hematology 1998

                        European Group for Blood and Marrow Transplantation  2003

                        Senologic International Society 2007

 
Presentations at International Meetings

 

1- Third international symposium on Bone Marrow Transplantation in Thalassemia; Pesaro, Italy September 29, 1996. “Jordanian experience in Thalassemia. Bone Marrow Transplantation”.

2- First international medical congress of the Royal Medical Services May, 1996. “Philadelphia Positive AML, Biological characteristics and treatment outcome” Holiday-Inn Amman.

3- First International Medical Congress of the Royal Medical Services May 17, 1996. “Testicular germ cell tumor at (KHMC) ”. Holiday Inn Amman.

4- First International Medical Congress of the Royal Medical Services May15, 1996. “Plasma lipid profile in a Jordanian population”. Holiday Inn Amman.

5- First international medical congress of the Royal Medical Services May,

1996. “Familial Mediterranean fever in Jordanians”. Holiday Inn Amman.

6- American Society of Hematology Forty-First Annual meeting December

1999 New Orleans LA, USA. M. Akasheh, M Abu-Hajir. The safety of Enoxaparin in patients older than 60 years with Non-APL AML or high risk MDS undergoing induction or consolidation chemotherapy. Blood. (Supplement) November 1999, abstract [4211].

7- 2000 Tandem BMT Meetings Anheim, California. March 27, 2000. Study #MM98-02 Development of Disease-Specific data collection form for Waldenstorm Macroglobulinemia.

8- The 2000 Tandem BMT Meetings Anheim, California. March 27, 2000. Study# MM00-01 Principle Investigator: High-Dose Therapy for patients with Primary Systemic Amyloidosis.

9- American Society of Hematology December 2000 San Francisco, California. Engraftment syndrome after autologous hematopoietic stem cell transplantation supported by granulocyte colony-stimulating factor or granulocyte-macrophage colony-stimulating factor.

10- American Society of Hematology December 2000 San Francisco, CA.

Melphalan associated pulmonary toxicity following high-dose therapy with autologous hematopoietic stem cell transplantation.

12- American Society of Clinical Oncology meeting May 2001 San Francisco, CA. Routine liver imaging is unnecessary in the work-up of T1-2 N0-1 breast cancer.

13- The First International Medical Conference November 2001 King Hussein Medical Center; Amman. The first 60 cases of Hematopoietic Stem Cell Transplantation.

14- The Third Jordanian Oncology Conference September 2001, Amman. Myelodysplastic Syndrome: A review from King Hussein Medical Center.

15- The 2002 Meeting of the European Group for Blood and Marrow Transplantation Montreaux, Switzerland. The effect of religious faith and Family support on the quality of life of patients undergoing Hematopoietic Stem Cell Transplantation (Poster).

16- The 2002; 27th European Society of Clinical Oncology Congress: Nice, France. Phase I/II study of multiple cycles of high-dose iv melphalan for elderly patients with multiple myeloma without stem cell rescue (Poster).

17- The Second International Medical Conference of the Royal Medical Services: Amman. Routine Liver Imaging is Unnecessary in T1-2 N0-1 Breast Cancer.

18- American Society of Hematology annual meeting December 2003 San Diego, CA. David Vesole, Waleska Perez, D. E. Reece, Marwan Akasheh, M Horowitz. High-dose therapy with Autologous Hematopoietic Stem Cell Transplantation for patients with primary systemic amyloidosis (AL): results from the autologous blood and marrow transplant registry (ABMTR).

19- Future of Surgical Training 23-25 August 2007. Local  Perspectives in Gastric Cancer Therapy. Amman-Jordan Radisson Hotel

 

 

Continuous Medical Education credit

 

American Society of Clinical Oncology meeting in L.A. May 1998.

Southeastern Wisconsin Cancer Conference Milwaukee WI. April 1998-4 credit hours.

Educational fall meeting of the American Society of Clinical Oncology in IL. Nov. 1998-8.5 credit hours.

American Society of Hematology meeting in Miami, FL. Dec.1998.

American Society of Clinical Oncology meeting in Atlanta, GA. May 1999-10.75 hours.

ACP-ASIM Wisconsin Chapter Milwaukee, WI. Sept. 1999.

American Society of Hematology meeting New Orleans, LA 1999-14 credit hours.

ACP-ASIM annual meeting in Philadelphia, PA 2000-18 credit hours,

MKSAP Hematology 1999-50 credit hours

MKSAP 11 1999-144 credit hours

Tandem Bone Marrow Transplant meeting; Anheim, CA 2000.

COMO (Congress Oriental Medical Oncology) April 2001, Beirut-Lebanon.

European Bone Marrow Transplant Meeting: Montreux-Switzerland March, 2002.

European Society of Medical Oncology 28th Meeting, Nice-France October 2002.

The European Cancer Conference Copenhagen 12: Copenhagen-Denmark September 2003.

European Society of Medical Oncology 29th Meeting, Vienna: Austria October 29, 2004.

1st  Novartis Middle East & Africa Oncology Summit January 2005 Dubai.

American College of Physicians Annual meeting Philadelphia April, 2006

European Bone Marrow Transplant Meeting; Hamburg-Germany March, 2006

The European Society of Urology annual meeting:Amsterdam June 2006

Lebanese Society of Medical Oncology. Best of ASCO November 17-18, 2006 Lebanon

European Society of Medical Oncology 32 Meeting, Barcelona: Spain September15, 2007.

Pfizer Principle Investigator meeting on Sutent: Paris August 15,2008

European Society of Medical Oncology 33 Meeting, Stockholm: Sweden September 13, 2008.

 

GRANTS

 

Winner of the Fellowship Exchange Program Award 2004 Sponsored by the American College of Physicians.

 

PUBLICATIONS

 

 

1.      Akasheh MS. Graves’ disease mimicking B-thalassemia trait. Postgrad Med J 1994; 70:300-1.

2.      Akasheh MS. Still Hazy after all these years. N Eng J Med 1995; 332:332-3.

3.      Akasheh MS, et al Rapidly progressive renal failure complicating acute rheumatic fever. Postgrad Med J 1995; 71:553-4.

4.      A. Najada, MS Akasheh, et al Congenital afibrinogenemia and familial combined hyperlipidemia in a kindred. Bahrain Medical Bulletin 1996; 8(4):133-6.

5.      M. Karadsheh, MS Akasheh, et al Plasma lipid profile in the male population of the Jordanian armed forces. Bahrain Medical Bulletin 1996; 18(3):89-91.

6.      M. Akasheh, K Omari, F Madanat. Skin rash in a jaundiced patient. Postgrad Med J 1997;73: 677-8.

7.      K. Omari, M Akasheh, et al. Jordanian experience in Thalassemia. Bone Marrow Transplantation 1997, March (supplement):94-5.

8.      MS Akasheh et al. Pseudomyxoma peritonei. The Practitioner No.2.1998

9.      F.Madanat, M Akasheh. HELLP Syndrome with ruptured liver. The Practitioner 1998, April; 6 :116-9.

10.  Marwan Akasheh. A case of central nervous system chloroma. Grand Rounds Publication. Medical College of WI. Volt 5, No 4. Sept. 1998.

11.  Marwan Akasheh, David Vesole. Bloody diarrhea in a bone marrow transplant recipient. Grand Rounds Publication. Vol5, No 4. Sept. 1998.

12.   MS Akasheh et al. Accelerated atherosclerosis in a patient with post BMT-Nephropathy. Bone Marrow Transplantation 1999; 22:199-201.

13.  MS Akasheh, D. Vesole. Acute Tumor Lysis; A case in AL-Amyloidosis. British J Haematology 1999;107: 386-387.

14.  M Akasheh, C Freytes, D Vesole. Melphalan associated pulmonary toxicity following high-dose therapy with autologous hematopoietic stem cell transplantation. Bone Marrow Transplantation 2000; 26:1107-9.

15.  M Akasheh, M Abu-Hajir. The safety of Enoxaparin in patients older than 60 years with Non-APL AML or high risk MDS undergoing induction or consolidation chemotherapy. Blood. (Supplement) November 1999, abstract [4211].

16.  M. Akasheh, M. Abu-Hajir. The safety of Enoxaparin in patients older than 60 years with Non-APL AML or high risk MDS undergoing induction or consolidation chemotherapy. Thrombosis in Oncology, December 2000.

17.  M Akasheh, F Mdanat, A Telfah et al. Routine liver imaging is unnecessary in the work-up of T1-2 N0-1 breast cancer. ASCO Proceedings, May 2001.

18.  M Akasheh. Myeloblastoma of the central nervous system. Journal of the Royal Medical Services, December 2001.

19. K Omari,  M Akasheh, et al. The effect of religious faith and Family support on the quality of life of patients undergoing Hematopoietic Stem Cell Transplantation (Poster). Meeting of the European Group for Blood and Marrow Transplantation Montreaux, Switzerland. Bone Marrow Transplantation Vol 29, Supplement 2 March 2002.

 

20. M Akasheh, A Telfah. Routine liver imaging is unnecessary in the work-up of T1-2 N0-1 breast cancer. Annal Saudi Med. Vol 22, No. 3-4. July 2002.

21. K Omari,  M Akasheh, et al. Phase I/II study of multiple cycles of high-dose iv melphalan for elderly patients with multiple myeloma without stem cell rescue (Poster). Annals of Oncology Vol 13, Supplement (5) 2002.

21. M Akasheh, MAbu-hajir. The safety of enoxaparin in patients older than 60 years with acute myelogenous leukemia or high risk myelodysplastic syndrome undergoing chemotherapy. Bahrain Medical Bulletin, Vol. 24, No.2, June 2002

22. M Akasheh, D Eastwood, D H Vesole. Engraftment syndrome after autologous hematopoietic stem cell transplant supported by granulocyte-colony stimulating factor (G-CSF) versus granulocyte macrophage-colony stimulating factor (GM-CSF). Bone Marrow Transplantation 2003; 31: 113-7.

23. David Vesole, Waleska Perez, D. E. Reece, Marwan Akasheh, M Horowitz. High-dose therapy with Autologous Hematopoietic Stem Cell Transplantation for patients with primary systemic amyloidosis (AL): results from the autologous blood and marrow transplant registry (ABMTR). Blood (Supplement) November 16 2004, [abstract].

24. D Vesole, W Perez, M Akasheh et al. High Dose Therapy and Autologous Hematopoietic Stem CellTransplantation (HSCT) for Patients With Primary Systemic Amyloidos(AL): A CIBMRT Study. Mayo Clinic Proceedings 2006;81 (7):880-888.